Mercer Global Advisors
AEON icon

Mercer Global Advisors’s AEON Biopharma AEON Stock Holding History

Mercer Global Advisors’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58 Buy
+80
New +$67 ﹤0.01% 6002

Other funds holding AEON

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Mercer Global Advisors's AEON Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in AEON Biopharma (AEON) in Q2 2026: 80 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #6002 among its holdings.

14 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Mercer Global Advisors held 80 shares of AEON Biopharma worth $58 as of Q2 2026.
  • AEON Biopharma was a new Mercer Global Advisors position in Q2 2026.
  • AEON Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6002 holding.
  • 14 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.